Surgical Treatment and Prognosis Analysis of 142 Cases of Hilar Cholangiocarcinoma

赵建勋,史继荣,杨尹默,黄莚庭
DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2004.11.009
2004-01-01
Abstract:Objective To compare effects of several kinds of surgical treatments on prognosis of hilar cholangiocarcinoma. Methods The clinical data of 142 patients with hilar cholangiocarcinoma surgically treated in our hospital from 1983 to 2003 were retrospectively analyzed. Results The 142 were divided into the resection group (n=103) and drainage group (n=39) according to different kinds of treatments. In the resection group, the 1-, 2-, 3-, and 5-year survival rates were 90.61%, 59.55%, 40.23%, 24.76% and 49.60%, 8.77%, 4.38%, 4.38% in radical and palliative resection subgroups, respectively. In the drainage group, the 1-year survival rate was 26.00% and 37.31% in laparotomized and non-laparotomized drainage subgroups, respectively. None of the patients in the drainage groups survived for over 2 years. In the resection group, the 1-, 2-3-and 5-year survival rates were 87.43%, 51.04%, 36.46%, 25.52% and 55.82%, 22.41%, 12.80%, 6.4% for the patients undergoing hepatectomy and those not undergoing hepatectomy, respectively. Conclusions Exact preoperative evaluation of resectability, choosing a rational surgical procedure and using a rational approach of hepatectomy are important to prolong postoperative survival time of patients with hilar cholangiocarcinoma. Radical resection is the best choice. In the laparotomy, palliative resection is better than simple bypass operation. Internal drainage with biliary stent is better than PTCD in the non-operative treatment.
What problem does this paper attempt to address?